3M Cos. (NYSE:MMM) announced it has entered into an agreement to buy disinfectant-products maker Ivera.
Ivera’s lead product, the Curos I.V. port-connector cap, is used to help prevent catheter-related blood-stream infections, or CRBSIs. 3M said the product will complement its Tegaderm line of antimicrobial I.V. securement dressings.
Ivera Medical is taking a new tactic in targeting rival Catheter Connections, accusing the company of falsely advertising its catheter protection caps as U.S.-made.
Group purchasing organization Premier healthcare alliance signed a deal with Ivera Medical for disinfection devices. The contract makes Ivera the sole service provider for the GPO’s 2,900-hospital network for 3 years.
San Diego, Calif.-based Ivera will provide its line of Curos products, passive disinfection devices for needle-less IV valves and male-luer connectors.
The FDA granted W.L. Gore & Associates the first U.S. clearance for using an endovascular graft to treat tears or ruptures in the aortic wall.
Gore’s Conformable TAG thoracic endoprosthesis was approved as a treatment for a transection or tear in the aortic wall, an injury typically the result of a car accident, crushing of the chest or a fall from a high place, according to an FDA release.